Dr Carolyn Staton
PhD, MBiochem, SFHEA
Clinical Medicine, School of Medicine and Population Health
Senior Lecturer in Medical Education
+44 114 215 9063
Full contact details
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
91Ö±²¥
S10 2RX
- Profile
-
For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk
I joined the University in 1997 as a PhD student. During the course of my PhD, I discovered a number of novel anti-angiogenic agents which were patented by the University of 91Ö±²¥ and led to me being given the AACR – Novartis Scholar In Training Award (2000) and the BACR Translational Research Award (2005) - both in open competition.
In 2004 I was appointed to a lectureship and was awarded the Certificate in Learning and Teaching in 2009. In 2013 I designed and established the MSc(Res) in Translational Oncology and in 2016 I became a Senior Fellow of the Higher Education Academy and Senior Lecturer. I was the departmental director of learning and teaching for the Department of Oncology & Metabolism from 2018-2021.I am currently the Director of Intercalated Studies, the Deputy Director of the Personal Academic Tutoring scheme, the medical school Disability Liaison officer for PGT, and the History of Medicine Lead. I am also a member of the University Discipline Committee.
- Research interests
-
My current research interests are student perceptions and decision-making processes around intercalation.
Collaborative research with colleagues in 91Ö±²¥ also includes investigations into incidentaloma in modern medicine, the challenges and potential solutions.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Experimental and Molecular Pathology, 99(1), 19-24.
- . Cancer Chemother Pharmacol, 73(2), 259-270.
- . Histopathology, 62(6), 908-915.
- . Expert Opin Drug Discov, 7(8), 723-743.
- . Int J Exp Pathol, 93(2), 81-103.
- . Int J Exp Pathol, 93(1), 70-77.
- . Cancer Biomark, 12(2), 49-64.
- . Front Physiol, 2, 89.
- . Histopathology, 59(2), 274-282.
- . Br J Dermatol, 165(1), 221-224.
- . Mol Cancer, 10, 27.
- . Breast Cancer Res Treat, 128(3), 691-701.
- . Mol Cancer, 9, 276.
- . Br J Dermatol, 163(5), 920-927.
- . Br J Surg, 96(12), 1484-1491.
- . Br J Cancer, 101(4), 666-672.
- . Int J Exp Pathol, 90(3), 195-221.
All publications
Books
Journal articles
- . Analyst, 142(11), 2038-2049.
- . Metabolomics, 11(6), 1743-1755.
- . Experimental and Molecular Pathology, 99(1), 19-24.
- . Cancer Chemother Pharmacol, 73(2), 259-270.
- . International Journal of Surgery, 11(8), 600-600.
- . International Journal of Surgery, 11(8), 624-624.
- . Histopathology, 62(6), 908-915.
- . Expert Opin Drug Discov, 7(8), 723-743.
- . Int J Exp Pathol, 93(2), 81-103.
- . Int J Exp Pathol, 93(1), 70-77.
- . Cancer Biomark, 12(2), 49-64.
- . Biochem Soc Trans, 39(6), 1565-1570.
- . Front Physiol, 2, 89.
- . Histopathology, 59(2), 256-263.
- . Histopathology, 59(2), 274-282.
- Functional studies in two angiosarcoma cell lines.. J Clin Oncol, 29(15_suppl), e20511.
- . Int J Exp Pathol, 92(4), 219-231.
- . Br J Dermatol, 165(1), 221-224.
- . Mol Cancer, 10, 27.
- . Breast Cancer Res Treat, 128(3), 691-701.
- . J Tissue Eng Regen Med, 5(5), 363-374.
- . Mol Cancer, 9, 276.
- . Br J Dermatol, 163(5), 920-927.
- . Br J Cancer, 102(3), 594-601.
- . Br J Surg, 96(12), 1484-1491.
- . EXPERT OPIN DRUG DIS, 4(9), 961-979.
- . Br J Cancer, 101(4), 666-672.
- . Int J Exp Pathol, 90(3), 195-221.
- . Br J Cancer, 99(12), 1961-1966.
- . European Journal of Surgical Oncology (EJSO), 34(10), 1194-1194.
- . Breast Cancer Res, 10(2), 204.
- . Gut, 56(10), 1426-1432.
- . Angiogenesis Assays: A Critical Appraisal of Current Techniques.
- . J Pathol, 212(3), 237-248.
- . J Thromb Haemost, 5(4), 846-854.
- . J Cell Mol Med, 9(2), 286-302.
- . Int J Exp Pathol, 85(5), 233-248.
- . Microcirculation, 11(6), 531-532.
- . Blood, 103(2), 601-606.
- . Expert Opin Biol Ther, 3(7), 1105-1120.
- . Br J Cancer, 86(11), 1813-1816.
- . Angiogenesis, 4(4), 269-275.
- Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.. Cancer Res, 60(17), 4719-4724.
- . Microbiology, 144 ( Pt 1), 229-239.
Chapters
- Tubule Formation Assays In Staton C, Lewis CE & Bicknell R (Ed.), Angiogenesis Assays: A Critical Appraisal of Current Techniques (pp. 65-88). Wiley-Blackwell
- Alphastatin: a pluripotent inhibitor of activated endothelial cells In Siemann DW (Ed.), Vascular-targeted therapies in oncology (pp. 205-220). Wiley-Blackwell
- Haemostatic Regulators as drug targets in tumour angiogenesis In Weber GF (Ed.), Cancer therapy (pp. 187-220). Taylor & Francis
- Effects of fibrinogen and associated peptide fragments on the activation of human endothelial cells by VEGF in vitro In Harmey JH (Ed.), VEGF and Cancer (pp. 117-132). Springer
Conference proceedings papers
- Comparison and Optimisation of a strategy to isolate a single cell population of epithelial cells from the crypt compartment of the murine colon. BRITISH JOURNAL OF SURGERY, Vol. 100 (pp 99-99)
- Neuropilin-1 expression in the normal colon is enteroendocrine-like. BRITISH JOURNAL OF SURGERY, Vol. 100 (pp 123-123)
- Why do Patients get Metachronous Colorectal Adenomas?. JOURNAL OF PATHOLOGY, Vol. 228 (pp S3-S3)
- Neuropilin-1: A predictor of early carcinogenesis in the colonic epithelium. BRITISH JOURNAL OF SURGERY, Vol. 99 (pp 24-24)
- Faecal butyrate levels have different effect on cancer and adenoma tissues: Suggestion of early beneficial role of butyrate during carcinogenesis. BRITISH JOURNAL OF SURGERY, Vol. 99 (pp 29-29)
- Targeting VEGF in Human Angiosarcoma Cell Lines in Vitro. EUROPEAN JOURNAL OF CANCER, Vol. 47 (pp S665-S665)
- SERUM BIOMARKERS IN LUNG CANCER PATIENTS FROM TWO CLINICAL TRIALS OF CHEMOTHERAPY WITH OR WITHOUT THALIDOMIDE. J THORAC ONCOL, Vol. 6(6) (pp S1058-S1059)
- . JOURNAL OF CLINICAL ONCOLOGY, Vol. 29(15)
- . Tumor Biology
- ADAMTS-4 may regulate VEGF-stimulated angiogenesis. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 91(6) (pp A32-A33)
- Molecular interactions of ADAMTS-4 in the VEGFR2 signalling complex. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 91(2) (pp A30-A30)
- The molecular interactions involved in VEGF-induced signalling pathways. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 90(2) (pp A114-A114)
- . BREAST CANCER RESEARCH, Vol. 10 (pp S24-S24)
- . BREAST CANCER RESEARCH, Vol. 10 (pp S38-S38)
- Teaching interests
-
I am passionate about student support and welfare and am the Disability Liaison Officer for the Medical School PGT students and the deputy academic director of the Personal Academic Tutor scheme (MBChB) and an associate director of student affairs. I am a personal academic tutor and/or mentor for undergraduate medical students, PGT and PGR students in the Medical school and was nominated for Best Academic Mentor in the Annual Academic Awards 2018.
- Teaching activities
-
I am the Director of Intercalation studies and am the course lead of the BSc Medical Sciences Research and the BSc Medical Sciences (Surgery). I am also the History of Medicine SSC lead, the deputy ILA lead (phase 1 and 2), and involved in physiology teaching for first-year MBChB students as well as assessment setting and quality assurance.
I lead the Tumour Microenvironment and Literature Review modules on the MSc(Res) in Translational Oncology course and teach on the MSc in Molecular Medicine course.
- Professional activities and memberships
-
- Senior Fellow of the Higher Education Academy
- Director of Intercalated Studies
- Disability Liaison Officer for Medical School PGT
- Academic Lead – BSc Medical Sciences Research
- Academic Lead – BSc Medical Sciences (Surgery)
- Academic Lead – History of Medicine SSC
- Deputy Academic Director of the Personal Academic Tutor scheme for MBChB
- Honorary Treasurer – British Microcirculation Society (2016-2021)
- External Examiner at the University of Nottingham & Hull